Nuevo paradigma de tratamiento en cáncer de ovario: evidencia clínica de olaparib

Previous Page

Next Page

Page Background

Agenda

•

From preclinical data to the approvals in recurrent ovarian

cancer

•

Olaparib in front line ovarian cancer

•

A view to the future